TG Therapeutics Inc. (NASDAQ:TGTX) shares advanced Wednesday after the biopharmaceutical company announced the completion of a $100 million share repurchase program and unveiled plans for an ...
TG Therapeutics recently completed a US$100 million share repurchase program, buying back approximately 3.5 million shares, and the Board of Directors has authorized an additional US$100 million ...
TG Therapeutics (TGTX) announced that it has completed its previously authorized $100M share repurchase program, which was initially announced in August 2024. Under that program, the Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback